KnowraStatinLinked fromLinked fromThe 26 pages that link to Statin, each with the reason it gives.All 26Broader topic 1Related 16Narrower topic 3Compared with 6AtherosclerosisRelated: Statins lower LDL cholesterol and reduce the risk of atherosclerotic cardiovascular events.CholesterolRelated: Statins reduce liver cholesterol synthesis and increase removal of LDL from blood.Cardiovascular diseaseRelated: Statins reduce atherosclerotic events by lowering LDL cholesterol and stabilizing plaques.Coronary artery diseaseRelated: Statins reduce atherosclerotic risk and are central to secondary prevention.Metabolic syndromeRelated: Statins may reduce cardiovascular risk when the overall lipid and risk profile warrants treatment.Low-density lipoproteinRelated: Statins reduce LDL chiefly by increasing hepatic removal of LDL particles.Familial hypercholesterolemiaRelated: Statins are usually the first-line medicines for lowering LDL in affected people.Mevalonate pathwayRelated: Statins directly block the pathway’s regulated, rate-limiting enzyme.Secondary preventionRelated: After cardiovascular disease, statins reduce the risk of another event.Atherosclerotic cardiovascular diseaseRelated: Statins lower cardiovascular event risk by reducing LDL cholesterol and stabilizing plaques.Lipid metabolismRelated: Statins therapeutically suppress a rate-limiting step in cholesterol synthesis.DyslipidemiaRelated: Statins are the principal medication class for reducing LDL-related cardiovascular risk.SterolRelated: Statins reduce production of the most prominent animal sterol.UbiquinoneRelated: The pathway inhibited by statins also supplies precursors for ubiquinone synthesis.High cholesterolRelated: Statins are the main drug treatment for reducing cholesterol-related cardiovascular risk.Konrad Emil BlochRelated: The pathway Bloch helped establish later supplied the biochemical target for statin therapy.
KnowraStatinLinked fromLinked fromThe 26 pages that link to Statin, each with the reason it gives.All 26Broader topic 1Related 16Narrower topic 3Compared with 6AtherosclerosisRelated: Statins lower LDL cholesterol and reduce the risk of atherosclerotic cardiovascular events.CholesterolRelated: Statins reduce liver cholesterol synthesis and increase removal of LDL from blood.Cardiovascular diseaseRelated: Statins reduce atherosclerotic events by lowering LDL cholesterol and stabilizing plaques.Coronary artery diseaseRelated: Statins reduce atherosclerotic risk and are central to secondary prevention.Metabolic syndromeRelated: Statins may reduce cardiovascular risk when the overall lipid and risk profile warrants treatment.Low-density lipoproteinRelated: Statins reduce LDL chiefly by increasing hepatic removal of LDL particles.Familial hypercholesterolemiaRelated: Statins are usually the first-line medicines for lowering LDL in affected people.Mevalonate pathwayRelated: Statins directly block the pathway’s regulated, rate-limiting enzyme.Secondary preventionRelated: After cardiovascular disease, statins reduce the risk of another event.Atherosclerotic cardiovascular diseaseRelated: Statins lower cardiovascular event risk by reducing LDL cholesterol and stabilizing plaques.Lipid metabolismRelated: Statins therapeutically suppress a rate-limiting step in cholesterol synthesis.DyslipidemiaRelated: Statins are the principal medication class for reducing LDL-related cardiovascular risk.SterolRelated: Statins reduce production of the most prominent animal sterol.UbiquinoneRelated: The pathway inhibited by statins also supplies precursors for ubiquinone synthesis.High cholesterolRelated: Statins are the main drug treatment for reducing cholesterol-related cardiovascular risk.Konrad Emil BlochRelated: The pathway Bloch helped establish later supplied the biochemical target for statin therapy.